» Articles » PMID: 20083680

Arterial Stiffness and Cardiovascular Events: the Framingham Heart Study

Overview
Journal Circulation
Date 2010 Jan 20
PMID 20083680
Citations 949
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Various measures of arterial stiffness and wave reflection have been proposed as cardiovascular risk markers. Prior studies have not assessed relations of a comprehensive panel of stiffness measures to prognosis in the community.

Methods And Results: We used proportional hazards models to analyze first-onset major cardiovascular disease events (myocardial infarction, unstable angina, heart failure, or stroke) in relation to arterial stiffness (pulse wave velocity [PWV]), wave reflection (augmentation index, carotid-brachial pressure amplification), and central pulse pressure in 2232 participants (mean age, 63 years; 58% women) in the Framingham Heart Study. During median follow-up of 7.8 (range, 0.2 to 8.9) years, 151 of 2232 participants (6.8%) experienced an event. In multivariable models adjusted for age, sex, systolic blood pressure, use of antihypertensive therapy, total and high-density lipoprotein cholesterol concentrations, smoking, and presence of diabetes mellitus, higher aortic PWV was associated with a 48% increase in cardiovascular disease risk (95% confidence interval, 1.16 to 1.91 per SD; P=0.002). After PWV was added to a standard risk factor model, integrated discrimination improvement was 0.7% (95% confidence interval, 0.05% to 1.3%; P<0.05). In contrast, augmentation index, central pulse pressure, and pulse pressure amplification were not related to cardiovascular disease outcomes in multivariable models.

Conclusions: Higher aortic stiffness assessed by PWV is associated with increased risk for a first cardiovascular event. Aortic PWV improves risk prediction when added to standard risk factors and may represent a valuable biomarker of cardiovascular disease risk in the community.

Citing Articles

Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study.

Kim H, Park Y, Ko S, Cho Y, Kim H, Kim Y Sci Rep. 2025; 15(1):7832.

PMID: 40050367 PMC: 11885479. DOI: 10.1038/s41598-025-91835-x.


A framework of biomarkers for vascular aging: a consensus statement by the Aging Biomarker Consortium.

Zhang L, Guo J, Liu Y, Sun S, Liu B, Yang Q Life Med. 2025; 2(4):lnad033.

PMID: 40040784 PMC: 11879419. DOI: 10.1093/lifemedi/lnad033.


Predictive Value of Cardiopulmonary Exercise Testing Parameters in Patients under Percutaneous Coronary Intervention with High Pulse Pressure.

Ren Q, Mu X, Li Y, Zhang J, Liang Y, Zhang Q Rev Cardiovasc Med. 2025; 26(2):25847.

PMID: 40026507 PMC: 11868889. DOI: 10.31083/RCM25847.


Association between perceived discrimination and pulse wave velocity: a scoping review.

Pagan Lassalle P, Paterson C, Kerr Z, Gibbs B, Moore J, Meyer M BMJ Public Health. 2025; 2(2):e001137.

PMID: 40018593 PMC: 11816527. DOI: 10.1136/bmjph-2024-001137.


Assessing the Validity of Computerized Algorithms for Determining Pulse Wave Velocity: A Clinical Study.

Tairi A, Obeid H, Addour S, Butlin M, Avolio A, Fortier C Pulse (Basel). 2025; 13(1):62-71.

PMID: 39991444 PMC: 11842098. DOI: 10.1159/000543354.


References
1.
Williams B, Lacy P, Thom S, Cruickshank K, Stanton A, Collier D . Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006; 113(9):1213-25. DOI: 10.1161/CIRCULATIONAHA.105.595496. View

2.
Seals D, Tanaka H, Clevenger C, Monahan K, Reiling M, Hiatt W . Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol. 2001; 38(2):506-13. DOI: 10.1016/s0735-1097(01)01348-1. View

3.
Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

4.
Mattace-Raso F, van der Cammen T, Hofman A, van Popele N, Bos M, Schalekamp M . Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006; 113(5):657-63. DOI: 10.1161/CIRCULATIONAHA.105.555235. View

5.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R . European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by.... Eur J Cardiovasc Prev Rehabil. 2007; 14 Suppl 2:S1-113. DOI: 10.1097/01.hjr.0000277983.23934.c9. View